Skip to content
Picture of Olivier Laureau, President of Servier

Olivier Laureau

President of Servier

Olivier Laureau is President of the Servier Group and the Servier International Foundation for Research.

A graduate of the Panthéon-Assas University in Paris, France, Olivier Laureau joined the Servier Group in 1982 in the Intellectual Property Department before joining the Legal Department where he oversaw international contracts. In 2000, he joined the Finance Department and was appointed Chief Financial Officer of the Group in 2008.

As President of the Group since 2014, Olivier Laureau has undertaken a holistic transformation plan to value Servier’s independence, ensure the Group’s development and sustainability and fulfil its vocation: committed to therapeutic progress to serve patient needs.

The major aspects of this strategy are to maximize the potential of the Group’s medicines in cardiology, metabolism and venous diseases, to develop innovative and targeted therapies in the field of oncology, neuroscience and immuno-inflammation, and to drive the drug portfolio development, through a dynamic ecosystem policy, and a strong international expansion.

Deeply involved in the debates surrounding the healthcare sector at international level, Olivier Laureau is 2nd Vice-President and Board Member of the European Federation of Pharmaceutical Industries and Associations (EFPIA). He is also member of the Biopharmaceutical CEOs Roundtable (BCR), a global policy forum gathering CEOs of the member-companies of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA). In France, Olivier Laureau has been a member of the Board of Directors of the G5, an organization of leading French pharmaceutical companies, since 2014.

Logo of LinkedIn